Mirum researches, develops and commercializes novel therapies for the treatment of liver diseases.Read more
Mirum's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 8.1B. Over the last three quarters, Mirum's revenue has decreased by 71.5%. Specifically, in Q4 2021's revenue was $3.1M; in Q3 2021, it was $5M; in Q2 2021, it was $11M.